We found that the LD among these three SNPs of ERCC5 was incomplete in all control subjects (rs2094258 and rs2296147: r2 = 0.163; rs2094258 and rs873601: r2 = 0.438; rs873601 and rs2296147: r2 = 0.102), suggesting that variant haplotypes may play a role in cancer risk. Here, ERCC5 is linked to cancer.